Key Quantitative Figures

  • Open Offer Size: Up to 2,77,26,848 (Two Crore Seventy-Seven Lakh Twenty-Six Thousand Eight Hundred Forty-Eight) fully paid-up equity shares.
  • Face Value: ₹1 per share.
  • Offer Stake: 26.00% of the Expanded Voting Share Capital of Bliss GVS Pharma Limited (Target Company).
  • Offer Price: ₹299.00 per Equity Share.

Parties Involved

  • Acquirer: Anupam Rasayan India Limited.
  • Manager to the Offer: SBI Capital Markets Limited (SEBI Registration No. INM000003531).
  • New Person Acting in Concert (PAC): Mates Visa Consultancy Private Limited.
  • Target Company: Bliss GVS Pharma Limited.
  • Registrar to the Offer: MUFG Intime India Private Limited (SEBI Registration No. INR000004058).

Purpose / Rationale

The addendum is issued to inform the public shareholders of the Target Company about the addition of Mates Visa Consultancy Private Limited as a Person Acting in Concert (PAC) with the Acquirer (Anupam Rasayan India Limited) for the purposes of the Open Offer. This follows the Acquirer's completion of the acquisition of the entire equity share capital of Mates Visa, making it a wholly-owned subsidiary effective July 17, 2026.

Financial & Operational Impact

  • The inclusion of Mates Visa as a PAC is a consequential change to the original offer structure.
  • Mates Visa will acquire shares under the Share Purchase Agreement and the Open Offer alongside the Acquirer.
  • All corresponding changes will be incorporated in the final Letter of Offer to be sent to public shareholders.
  • The Acquirer and PAC accept full responsibility for the information and obligations under the SEBI (SAST) Regulations.

Details of the New PAC (Mates Visa Consultancy Private Limited)

  • Corporate Status: Private company, incorporated on May 25, 2022 (CIN: U74999HR2022PTC103913).
  • Contact: Mobile No. 9016564657.
  • Ownership: Wholly-owned subsidiary of Anupam Rasayan India Limited.
  • Capital: Authorized, issued, and paid-up share capital is ₹10,000, divided into 1,000 equity shares of ₹10 each.
  • Holdings: Does not hold any equity shares in Bliss GVS Pharma Limited.
  • Listing: Securities are not listed on any stock exchange.
  • Relationship: Declares no existing relationship or interest with the Target Company.

Financial Information of Mates Visa Consultancy Private Limited (Audited)

  • Revenue from Operations: FY26: ₹0.3140 Cr, FY25: ₹0.2942 Cr, FY24: ₹0.2845 Cr.
  • Profit/(Loss) After Tax: FY26: (₹0.0007) Cr, FY25: (₹0.0005) Cr, FY24: ₹0.0013 Cr.
  • Net Worth: FY26: ₹0.0010 Cr, FY25: ₹0.0017 Cr, FY24: ₹0.0022 Cr.
  • Earnings Per Share (Basic/Diluted): FY26: (₹0.07), FY25: (₹0.05), FY24: ₹0.13.
  • Book Value Per Share: FY26: ₹10.40, FY25: ₹16.90, FY24: ₹21.80.

Dates and Timeline

  • Public Announcement Date: May 23, 2026.
  • Detailed Public Statement Date: May 30, 2026 (published June 1, 2026).
  • Draft Letter of Offer Date: June 8, 2026.
  • PAC Acquisition Effective Date: July 17, 2026.
  • Addendum Date: July 17, 2026.
  • BSE/NSE Intimation Date: July 19, 2026.

Additional Information

The Addendum will be available on the website of SEBI at www.sebi.gov.in. The original Open Offer announcement was published in The Financial Express (all editions), Jansatta (Hindi Daily), and Navshakti (Mumbai edition, Marathi Daily).